Literature DB >> 10812816

Evaluation of endoscopy-based diagnostic methods for the detection of Helicobacter pylori.

S Saksena1, S Dasarathy, K Verma, V Ahuja, M P Sharma.   

Abstract

BACKGROUND: Helicobacter pylori is an etiological factor in duodenal ulcer. Few studies have objectively assessed the accuracy of diagnostic methods for the detection of H. pylori.
METHODS: The sensitivity and specificity of histology, touch smear, rapid urease test (RUT) and brush cytology of endoscopic antral biopsy from patients with duodenal ulcer were compared. Forty-nine patients were evaluated before, and 34 after, eradication therapy. Each time, sampling was done for all 4 tests. The infection status for each sample was established by a positive concordance of results of three of four tests.
RESULTS: The highest degree of agreement was between RUT and cytology (kappa = 0.69). Brush cytology (100%) followed by RUT (94.5%) were the most sensitive tests. Histology had the highest specificity (89.3%). A combination of RUT or brush cytology with histology had the maximum chance of detecting H. pylori. As single tests, brush cytology and touch smear had high diagnostic accuracies with a Youdin J value of 1.79 and 1.78, respectively.
CONCLUSION: The best method for diagnosis of H. pylori is a combination of the rapid urease test or brush cytology with histology. Brush cytology or touch smear are diagnostic tests of choice if a single test is desired.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10812816

Source DB:  PubMed          Journal:  Indian J Gastroenterol        ISSN: 0254-8860


  2 in total

1.  Efficacy and tolerability of rifampicin-based rescue therapy for Helicobacter pylori eradication failure in peptic ulcer disease.

Authors:  Vineet Ahuja; Vikram Bhatia; S Dattagupta; Akshay Raizada; Mahesh Prakash Sharma
Journal:  Dig Dis Sci       Date:  2005-04       Impact factor: 3.199

2.  Helicobacter pylori infection in India from a western perspective.

Authors:  Selvi Thirumurthi; David Y Graham
Journal:  Indian J Med Res       Date:  2012-10       Impact factor: 2.375

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.